RD3 and neuroblastoma: Human TMA data from the laboratory, clinical correlation data from manifold of neuroblastoma patient cohorts as well as the in vivo/ex vivo laboratory investigations unidirectionally dictates that RD3 loss mediates neuroblastoma progression.